JP Morgan Upgrades Teradyne to Overweight, Maintains Price Target to $400

Benzinga Newsdesk www.benzinga.com Positive 90.2%

Neg 0% Neu 0% Pos 90.2%

JP Morgan analyst Samik Chatterjee upgrades Teradyne (NASDAQ:TER) from Neutral to Overweight and maintains the price target from $400 to $400.